Fischer P, Pawlowski A, Cao D, Bell D, et al. Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women. Vaccine 2021 Jun 29. pii: S0264-410X(21)00796.
PMID: 34215454